---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-043733"
form_type: "8-K"
ticker: "ADIL"
cik: "0001513525"
company_name: "ADIAL PHARMACEUTICALS, INC."
filed_at: "2025-05-15T23:59:59+00:00"
generated_at: "2026-05-21T04:54:16.915508+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Adial Pharmaceuticals sets 2025 Annual Meeting for July 24; proposal deadlines revised

## Summary
- Annual meeting scheduled for July 24, 2025; record date June 4, 2025.
- Rule 14a-8 stockholder proposal deadline: May 25, 2025.
- Director nominations and non-14a-8 proposals due by May 25, 2025.
- Universal proxy rule compliance notice also due May 25, 2025.

## SEC filing metadata
- accession: 0001213900-25-043733
- form_type: 8-K
- ticker: ADIL
- cik: 0001513525
- company_name: ADIAL PHARMACEUTICALS, INC.
- filed_at: 2025-05-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.08, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1513525/000121390025043733/0001213900-25-043733-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1513525/000121390025043733/ea0242287-8k_adial.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-043733
- JSON: https://secwatch.observer/filing/0001213900-25-043733.json
- Plain text: https://secwatch.observer/filing/0001213900-25-043733.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.